Hyperglycemia leads to poorer clinical outcomes, with increased morbidity and mortality in both critically ill and non-critically ill people. Improving blood glucose levels reduces length of hospital stay, systemic infections and short- and long-term mortality. Egyptian physicians evaluated the efficacy of insulin degludec compared to insulin glargine and regular insulin in controlling blood glucose levels.
You May Also Like
- Progressive multiple sclerosis
New horizons: from BTK inhibitors to remyelination
- Cutaneous and especially facial metastases
Rare manifestations of esophageal carcinoma
- Rare pulmonary syndromes
Yellow nail and Swyer-James syndrome
- IMCAS Refresher: Aging Sciences/Plastic Surgery
Trends in aesthetic and regenerative medicine
- Pelargonium sidoides
Scoping review sheds light on the multifaceted spectrum of effects
- New evidence on genetics, pathophysiology and clinical significance
Migraine with and without aura – two different entities?
- Prevention of skin cancer
UV protection and skin cancer screening – Update 2025
- Case report: L. pneumophila pneumonia